InvestorsHub Logo

lasers

07/18/13 9:53 PM

#3916 RE: ARBITRARY & CAPRICIOUS #3914

It is not just a PR. The Melanoma PhaseII information waited for is the statistical data on the progress of the 25 patients. Final enrollment and treatment was completed on Jun 18, 2013.

Based, on the statistical response for the PhaseII OncoSec will then begin talks with the FDA to prepare for PhaseIIB Melanoma DNA-IL-12 planned for Dec 31, 2013.

http://oncosec.com/index.php/about-us/oncosec-milestones/#42

james2013

07/19/13 12:44 AM

#3917 RE: ARBITRARY & CAPRICIOUS #3914

LOL NON IMPACTFUL...
Do you know what will be non IMPACTFUL? Your attempts to drive the PPs down, all because you want to get on the boat a little lower... Reach up and get on now--- it's leaving the dock with or without you..
Lol. Non IMPACTFUL .....

BiotechGuy49

07/19/13 7:11 AM

#3920 RE: ARBITRARY & CAPRICIOUS #3914

I actually agree. I believe that the small amount of data won't have a huge effect on pps. I think it'll be a slow rise once people get in.